companydata.dkcompanydata.dk

ABL BIOTEC A/S: Financial statements 2017

CVR: 50811018

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -125,116 and a net result of DKK 1,139,039 compared with DKK 795,892 the year before. Equity in the 2017 report amounted to DKK 24,577,622. The solvency ratio was 98.8%. The company had 1 employee in the financial year.

Gross Profit
DKK -125,116
Profit/Loss
DKK 1,139,039
Equity
DKK 24,577,622
Total Assets
DKK 24,864,880
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--125K1.1M24.6M1
2016--118K796K24.5M1
2015--122K2.2M24.8M-
2014--100K3.8M23.7M-
2013--97K2.7M22.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ABL BIOTEC A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

ABL BIOTEC A/S: The 2016 annual report is outMay 24, 2017

ABL BIOTEC A/S has published its annual report for 2016. Gross profit came to DKK -117,780, and the net result was DKK 795,892.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named KONTORBUTIKKEN ApS and PAPIR EN GROS VIGGO TRANHOLM MADSEN ApS. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.

Source: annual report 2025, Danish Business Authority